Accessibility Menu
 
Zai Lab logo

Zai Lab

(NASDAQ) ZLAB

Current Price$18.09
Market Cap$2.09B
Since IPO (2017)+3%
5 Year-86%
1 Year-52%
1 Month-10%

Zai Lab Financials at a Glance

Market Cap

$2.09B

Revenue (TTM)

$460.16M

Net Income (TTM)

$175.54M

EPS (TTM)

$-1.61

P/E Ratio

-11.58

Dividend

$0.00

Beta (Volatility)

1.22 (Average)

Price

$18.09

Volume

66,330

Open

$18.39

Previous Close

$18.09

Daily Range

$17.84 - $18.69

52-Week Range

$15.96 - $44.34

ZLAB: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Zai Lab

Industry

Biotechnology

Employees

1,784

CEO

Ying Du, PhD

Headquarters

Shanghai, 201210, CN

ZLAB Financials

Key Financial Metrics (TTM)

Gross Margin

58%

Operating Margin

-50%

Net Income Margin

-38%

Return on Equity

-23%

Return on Capital

-30%

Return on Assets

-15%

Earnings Yield

-8.64%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.09B

Shares Outstanding

112.07M

Volume

66.33K

Short Interest

0.00%

Avg. Volume

702.19K

Financials (TTM)

Gross Profit

$269.64M

Operating Income

$229.43M

EBITDA

$158.25M

Operating Cash Flow

$150.79M

Capital Expenditure

$8.10M

Free Cash Flow

$158.89M

Cash & ST Invst.

$689.57M

Total Debt

$224.26M

Zai Lab Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$127.60M

+17.0%

Gross Profit

$65.27M

-2.6%

Gross Margin

51.15%

N/A

Market Cap

$2.09B

N/A

Market Cap/Employee

$1.12M

N/A

Employees

1,869

N/A

Net Income

$50.41M

+38.3%

EBITDA

$48.06M

+36.3%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$465.31M

-25.7%

Accounts Receivable

$106.12M

+18.7%

Inventory

$74.75M

+87.4%

Long Term Debt

$13.38M

-2.4%

Short Term Debt

$210.87M

+50.9%

Return on Assets

-14.97%

N/A

Return on Invested Capital

-30.34%

N/A

Free Cash Flow

$25.62M

+65.2%

Operating Cash Flow

$26.02M

+53.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IRONDisc Medicine, Inc.
$58.17-1.69%
AAPGASCENTAGE PHARMA GROUP INTERNATIONAL
$19.11-13.29%
LEGNLegend Biotech Corporation
$17.41-2.57%
TARSTarsus Pharmaceuticals, Inc.
$64.51-3.36%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%
INFYInfosys
$13.12+0.01%
QQQInvesco QQQ Trust
$582.06-0.02%

Questions About ZLAB

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.